Gordon Binder

Président chez Neuvogen, Inc.

Profil

Gordon M.
Binder is the founder of X-Chem, Inc. (Massachusetts) which was founded in 2009.
He currently holds the position of Chairman at Neuvogen, Inc. and Director at Pepperdine University.
In the past, he served as the Chief Executive Officer of Amgen, Inc. from 1982 to 2000.
He also held positions as Chairman of Biotechnology Innovation Organization and Pharmaceutical Research & Manufacturers of America.
From 2003 to 2009, he was a Director at ACADIA Pharmaceuticals, Inc. He has also served as a Director at Massachusetts Institute of Technology, California Institute of Technology, and Gilead Connecticut, Inc. Additionally, he was a Managing Director at Coastview Capital LLC.
In 2021, he became an Independent Director at Humacyte, Inc. He started his career as a Finance Manager at Ford Motor Co. in 1981 and later worked as a Financial Manager at Litton Industries, Inc. He also served as an Industry Expert at Pearl Street Venture Funds and as a Trustee at American Enterprise Institute for Public Policy Research.
He began his career as the Chief Financial Officer at System Development Corp.
Mr. Binder holds an MBA from Harvard University and Purdue University.
He also holds an MBA from Harvard Business School.

Postes actifs de Gordon Binder

Sociétés	Poste	Début
Neuvogen, Inc.	Président	-
Pepperdine University	Directeur/Membre du Conseil	-

Anciens postes connus de Gordon Binder

Sociétés	Poste	Fin
HUMACYTE, INC.	Directeur/Membre du Conseil	11/06/2024
Pearl Street Venture Funds	Private Equity Investor	01/04/2010
ACADIA PHARMACEUTICALS INC.	Directeur/Membre du Conseil	24/07/2009
AMGEN INC.	Directeur Général	01/01/2000
Litton Industries, Inc.	Corporate Officer/Principal	31/12/1981